NuGen Medical Devices Inc. (TSXV:NGMD)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Jul 29, 2026, 12:14 PM EST
NuGen Medical Devices Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.02 | -7.83 | -5.23 | -9.36 | -5.58 | -7.11 |
Depreciation & Amortization | 0.7 | 0.69 | 0.65 | 0.69 | 0.65 | 0.63 |
Asset Writedown & Restructuring Costs | 4.81 | 4.81 | - | - | - | 0.16 |
Stock-Based Compensation | - | - | 0.09 | 1.36 | 0.43 | 1.31 |
Other Operating Activities | 1.78 | -1.02 | 0.11 | 1.32 | 1.76 | 1.14 |
Change in Accounts Receivable | 0.03 | 0.04 | -0.08 | -0.02 | 0.01 | -0.01 |
Change in Inventory | -0.13 | -0.22 | -0.11 | -0.13 | -0.06 | -0 |
Change in Accounts Payable | 0.1 | -0.13 | -0.38 | -0.36 | 0.61 | -0.03 |
Change in Unearned Revenue | -0.01 | -0.02 | 0.03 | 0.02 | 0.04 | - |
Change in Other Net Operating Assets | -0.01 | 0.11 | 0.2 | -0.23 | 0.02 | -0.19 |
Operating Cash Flow | -3.75 | -3.57 | -4.71 | -6.71 | -2.13 | -4.1 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.6 | -0.3 | -0.01 | -0 | -0 | -0 |
Cash Acquisitions | - | - | - | - | - | 0.01 |
Other Investing Activities | -0.05 | -0 | -0 | -0.05 | - | - |
Investing Cash Flow | -0.65 | -0.3 | -0.01 | -0.05 | -0 | 0 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 10 | 6.58 | - | 0.13 |
Long-Term Debt Repaid | - | - | -0.03 | -0.87 | -0.08 | -0.05 |
Net Debt Issued (Repaid) | - | - | 9.97 | 5.71 | -0.08 | 0.08 |
Issuance of Common Stock | - | 0.06 | 1.24 | 1.39 | 0.67 | 5.51 |
Other Financing Activities | - | - | - | - | -0.08 | - |
Financing Cash Flow | - | 0.06 | 11.21 | 7.1 | 0.51 | 5.58 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.02 |
Net Cash Flow | -4.41 | -3.81 | 6.48 | 0.33 | -1.62 | 1.47 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.35 | -3.87 | -4.72 | -6.72 | -2.13 | -4.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2627.01% | -1499.59% | -467.79% | -2026.89% | -1399.36% | -2977.84% |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.04 | -0.02 | -0.06 |
Levered Free Cash Flow | -4.72 | -4.27 | -3.89 | -4.59 | -2.29 | -2.64 |
Unlevered Free Cash Flow | -2.67 | -2.36 | -2.84 | -3.82 | -1.66 | -1.88 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 0.01 |
Cash Income Tax Paid | - | - | - | 0.01 | 0 | 0 |
Change in Working Capital | -0.03 | -0.22 | -0.34 | -0.73 | 0.6 | -0.23 |